{"date":"2025-01-05","count":1,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6589-2025-01-05-1200-br0ecn","company_id":"6589","company":"台康生技","market":"上市","industry":"生技醫療","date":"2025-01-05","time":"12:00:21","subject":"本公司向衛生福利部食品藥物管理署(TFDA)申請生物相似藥品「益康平凍晶注射劑 420毫克(EIRGASUN vial 420 mg)」之生物藥品查驗登記，已完成送件","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：台康生技（6589），2025-01-05 12:00，「本公司向衛生福利部食品藥物管理署(TFDA)申請生物相似藥品「益康平凍晶注射劑 420毫克(EIRGASUN vial 」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}